The first example of Ir(III)-catalyzed
C–H activation/cyclization
with N-alkoxyamides as amidation reagents to simultaneously
form functionalized thiadiazine 1-oxide derivatives was developed.
This one-pot cascade protocol tolerated diverse functional groups
and readily constructed various heterocyclic frameworks in moderate
to good yield.
An effective and condition-controlled way to synthesize with high selectivity a variety of functionalized indoles with potent biological properties has been developed. Notably, 2,4-dialkynyl indole products were obtained by direct double CÀ H bond alkynylation, whereas alkynyl at the C4 position could convert to carbonyl to generate 2alkynyl-3,4-diacetyl indoles fast and effectively. Additionally, a one-pot relay catalytic reaction led to 2,5-di-alkynyl-3,4diacetyl indoles when using a carbonyl group as the directing group and by controlling the type and quantity of additives. A possible mechanism was proposed based on many studies including deuterium-exchange experiments, the necessary conditions of product conversion, and the effect of water on the reaction.
The
ruthenium-catalyzed remote ε-C–H alkylation of
phosphines with tertiary alkyl halides has been developed. This novel
PIII-directed C–H activation strategy tolerated
various functional groups and delivered a wide variety of modified
phosphines with excellent meta-site selectivity.
Preliminary mechanistic studies indicated that a PIII-assisted ortho-cyclometalation/remote σ-activation pathway
might be involved in this methodology.
Novel and efficient rhodium(iii)-catalyzed C–H bond activation and tandem annulation for the synthesis of structurally complex quinazolines have been successfully developed.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.